Rockledge, PA, United States of America

Ilya G Serebriiskii

USPTO Granted Patents = 7 


Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Rockledge, PA (US) (2011 - 2019)
  • Philadelphia, PA (US) (2001 - 2020)

Company Filing History:


Years Active: 2001-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Ilya G. Serebriiskii: Innovator in Cancer Treatment

Introduction

Ilya G. Serebriiskii is a prominent inventor based in Rockledge, PA (US), known for his significant contributions to cancer research and treatment. With a total of seven patents to his name, he has made strides in developing innovative systems and methods aimed at addressing genetic predispositions to prostate cancer.

Latest Patents

Among his latest patents, Serebriiskii has developed systems and methods for treating patients with a genetic predisposition to develop prostate cancer. These methods involve evaluating peripheral blood cells for the presence or quantity of gamma-H2AX foci and gene alterations that correlate with prostate cancer development. His work also includes the identification of agents effective in treating hyperproliferative disorders through the EGFR/NEDD9/TGF-β interactome.

Career Highlights

Serebriiskii has worked with esteemed institutions such as the Fox Chase Cancer Center and the Institute for Cancer Research. His research has focused on the intricate mechanisms of cancer development and the potential for targeted therapies.

Collaborations

Throughout his career, Serebriiskii has collaborated with notable colleagues, including Erica A. Golemis and Igor Astsaturov. These partnerships have furthered his research and contributed to advancements in cancer treatment methodologies.

Conclusion

Ilya G. Serebriiskii's innovative work in cancer research exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for new treatment options for patients facing genetic risks of prostate cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…